Metastron (Strontium Chloride, SR-89) - Summary

METASTRON SUMMARY

METASTRON^™
(Strontium-89 Chloride Injection)

Metastron is a sterile, non-pyrogenic, aqueus solution of Strontium-89 Chloride for intravenous administration. The solution contains no preservative.Each milliliter contains:    Strontium Chloride    10.9 - 22.6 mg
    Water for Injection    q.s. to 1 mLThe radioactive concentration is 37 MBq/mL, 1 mCi/mL, and the specific activity is 2.96-6.17 MBq/mg, 80-167 µCi/mg at calibration. The pH of the solution is 4 - 7.5.

Metastron (Strontium-89 Chloride Injection) is indicated for the relief of bone pain in patients with painful skeletal metastases.

The presence of bone metastases should be confirmed prior to therapy.

See all Metastron indications & dosage >>

METASTRON NEWS HIGHLIGHTS

Media Articles Related to Metastron (Strontium Chloride, SR-89)

New Treatment Eliminates Heel Pain Caused By Plantar Fasciitis
Source: Health News from Medical News Today [2008.12.01]

New Pain Management Training Boosts Patient Care, Royal Australian College Of General Practitioners
Source: Medical Students / Training News From Medical News Today [2008.12.01]

New Twist on Treatment of Foot Pain (HealthDay)
Source: Y! Health News Search RSS Feed [2008.12.01]

Rewiring Of Brain Responsible For Baffling Chronic Pain
Source: Neurology / Neuroscience News From Medical News Today [2008.11.30]

Lilly Withdraws Application For Additional U.S. Indication For Cymbalta(R) For Chronic Pain
Source: Clinical Trials / Drug Trials News From Medical News Today [2008.11.29]

more >>

Published Studies Related to Metastron (Strontium Chloride, SR-89)

Palliation of bone pain in prostate cancer using chemotherapy and strontium-89. A randomized phase II study. [2005.04]

Strontium oral load test in children with idiopathic hypercalciuria. [2007.09]

Changes in the levels of CD4+ and CD8+ T-lymphocytes after strontium-89 chloride therapy for painful bone metastases in patients correlate with treatment efficacy. [2007.06]

[Therapeutic efficacy of strontium-89-chloride for bone metastatic tumors without bone pain] [2007.03]

Successful pregnancy after ICSI with strontium oocyte activation in low rates of fertilization. [2006.12]

more >>

Clinical Trials Related to Metastron (Strontium Chloride, SR-89)

Docetaxel and Prednisolone With or Without Zoledronic Acid and/or Strontium Chloride Sr 89 in Treating Patients With Prostate Cancer Metastatic to Bone That Has Not Responded to Hormone Therapy [Recruiting]

2PX (Topical Strontium Chloride Hexahydrate) in Patients With Post-Amputation Stump Pain. [Completed]

Strontium Compared With Radiation Therapy in Treating Patients With Hormone-Refractory Prostate Cancer With Painful Bone Metastases [Active, not recruiting]

Doxorubicin and Strontium-89 With or Without Celecoxib in Treating Patients With Progressive Androgen-Independent Prostate Cancer and Bone Metastases [Active, not recruiting]

Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases [Active, not recruiting]

more >>